Organisations from the Middle East, India and Southeast Asia identified for preliminary consideration in two new award categories.
Five aeromedical service providers from across the Middle East and Asia have been identified for preliminary consideration under the Aeromedical Asia 2027 Excellence Awards, highlighting the importance of clinical care, international medical repatriation and mission coordination.
The initiative introduces two award categories designed to recognise the professionals and organisations responsible for managing complex medical transfers across international borders.
The categories are:
1. Excellence in International Medical Repatriation 2026
2. Asia’s Best Aeromedical Mission Coordination Provider 2026
Five Organisations Under Consideration
The following companies have been identified for further evaluation, listed in no particular order:
- Bluedot Air Ambulance — United Arab Emirates
- Air Medical 24X7 — United Arab Emirates / India
- ICATT Air Ambulance Services — India
- Savana Assistance — Indonesia
- Hope Medflight Asia — Singapore
These organisations provide services involving medical evacuation, international repatriation, medical escorts and patient transport coordination.
Their inclusion in the preliminary list reflects their relevance to the award categories and does not constitute a ranking or endorsement of their clinical performance.
The Human Responsibility Behind Every Medical Mission
Medical repatriation involves more than moving a patient between hospitals or countries. It requires careful planning, appropriate clinical support and effective communication among healthcare professionals.
For patients and their families, such journeys can be physically and emotionally demanding. The experience, professionalism and compassion of those involved are essential to delivering responsible care.
The new awards seek to acknowledge these contributions while encouraging higher professional standards across the aeromedical industry.
Independent Recognition Without Commercial Influence
The Aeromedical Asia 2027 Excellence Awards are strictly non commercial. Award consideration and selection are not linked to sponsorship, advertising, exhibition participation, financial contributions or commercial partnerships with the organiser.
Recognition is based solely on professional merit, demonstrated performance, clinical standards, patient safety and verifiable contributions to aeromedical services.
No organisation is required to enter into a commercial arrangement to qualify for consideration. Likewise, any existing business relationship does not provide an advantage in the selection process.
This principle is intended to preserve the independence, credibility and professional integrity of the awards.
An Independent Evaluation Process
The Aeromedical Asia 2027 Selection Board will assess the organisations against relevant criteria, including clinical capabilities, patient safety practices, medical coordination and supporting evidence of service delivery.
The five companies remain under preliminary consideration. Official nominations and award recipients will be determined following the evaluation process.
The organiser extends its sincere appreciation to the Selection Board for its commitment to a fair, independent and merit-based assessment.
Ultimately, excellence in aeromedical services should be reflected in professional integrity, clinical responsibility and the standard of care delivered to patients.
Behind every medical evacuation is a human life, and that responsibility must always come first.
Aeromedical Asia 2027 is scheduled for 17–18 February 2027.



